Welcome
How much do you know about chronic spontaneous urticaria (CSU)? Gain insight into the diagnosis and management of this complex and debilitating disease.
- Understand the economic and humanistic burden of CSU
- Get practical advice on diagnosing and treating CSU from world-leading experts
- Familiarise yourself with national and international urticaria guidelines
Explore our dedicated Learning Zone to learn more about managing CSU, including information on the pathophysiology, symptoms, and available treatment options for this common and debilitating skin disease. You can also visit our CSU Resources for more exciting independent content, including patient case studies.
A selection of Novartis-sponsored symposia and eLearning modules are also available to keep you updated on some of the latest innovations in the field of CSU.
Chronic spontaneous urticaria at EADV 2023
Catch up on this expert symposium on chronic spontaneous urticaria held live at EADV 2023.
From past to present: What’s next for CSU?
From past to present: What’s next for CSU?
CSU Resources
E-learning module and more
Managing CSU
Learn more about diagnosis and treatment of CSU
Industry-Sponsored Symposia
Revisit content from recent scientific congresses
Industry-Sponsored eLearning in Chronic Spontaneous Urticaria
Take part in our multiple eLearning activities
of interest
are looking at
saved
next event
CSU Resources and Managing CSU have been developed by EPG Health for Medthority. This content has been developed independently of the sponsor Novartis Pharma AG, who have had no editorial input into the content. EPG Health received unrestricted educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.
The industry-sponsored symposia and eLearning have been developed in collaboration with Novartis Pharma AG, with some content provided by Novartis Pharma AG. The views presented in the videos are those of the presenters and not necessarily those of the industry sponsor, Novartis Pharma AG. Any data on non- Novartis products are based on publicly available information at the time of content update. Prescribing information may vary depending on local health authority approval in each country. Before prescribing any product, always refer to the SmPC or product information approved in your local country.